National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.
Tonkin
Andrew
A
Barter
Philip
P
Best
James
J
Boyden
Andrew
A
Furler
John
J
Hossack
Ken
K
Sullivan
David
D
Thompson
Peter
P
Vale
Margarite
M
Cooper
Catherine
C
Robinson
Malia
M
Clune
Eleanor
E
D001053:Apolipoproteins / Q000097:blood; D001315:Australia; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008019:Life Style; D009520:New Zealand; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D014280:Triglycerides / Q000097:blood
D001053:Apolipoproteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014280:Triglycerides; D002784:Cholesterol